MusclePharm | 8-K: Current report
Aug 31, 2023 17:23 ET
MusclePharm | 8-K: Current report
Jul 19, 2023 15:06 ET
MusclePharm | 8-K: Current report
Mar 10, 2023 16:16 ET
MusclePharm | 8-K: Current report
Jan 11, 2023 17:02 ET
MusclePharm | 8-K: Current report
Jan 10, 2023 19:37 ET
MusclePharm | 8-K: Current report
Jan 9, 2023 14:41 ET
MusclePharm | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-White Winston Select Asset Fund Series Fund MP-18, LLC(8.80%),White Winston Select Asset Funds, LLC(8.80%), etc.
Dec 21, 2022 17:22 ET
MusclePharm | 8-K: Current report
Sep 29, 2022 16:33 ET
MusclePharm: Current report
8-K | MusclePharm Corp (0001415684) (Filer)
Sep 16, 2022 17:43 ET
MusclePharm | 8-K: Current report
Aug 23, 2022 16:53 ET
MusclePharm | 8-K: Current report
Aug 22, 2022 17:09 ET
MusclePharm | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Aug 16, 2022 17:54 ET
MusclePharm | 8-K: Current report
Jul 28, 2022 16:30 ET
MusclePharm | 4: Statement of changes in beneficial ownership of securities
Jul 28, 2022 16:17 ET
MusclePharm | 3: Initial statement of beneficial ownership of securities-Officer Rizvi Sabina
Jul 28, 2022 16:15 ET
MusclePharm | 8-K: Current report
Jul 12, 2022 17:00 ET
MusclePharm | 3: Initial statement of beneficial ownership of securities-Chief Accounting Officer Chin Eric
Jun 22, 2022 16:15 ET
MusclePharm | 8-K: Current report
Jun 22, 2022 16:05 ET
MusclePharm | S-1: General form for registration of securities under the Securities Act of 1933
Jun 16, 2022 21:21 ET
MusclePharm | 8-K: Current report
Jun 14, 2022 16:10 ET
No Data
No Data